AzTrials
AzTrials

COVID-19NCT04896060

The Impact of the COVID-19 Pandemic on Eating Behavior and Weight Change

An observational study of COVID-19 and Obesity, run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Background: The indirect effects of the COVID-19 pandemic on mental health are of increasing concern. Perceived stress can lead to binge eating and weight gain. Researchers want to learn more about the relationship between eating behavior and the pandemic. Read more about this study

Who is it for?
Ages 18 to 99 years
Conditions the study is for
COVID-19, Obesity
How many people
5,056 participants
Where
1 siteUnited States
Study dates
1 Sep 2022to 13 Feb 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 99 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Volunteers of any health status, sex, or gender who are at least 18 years old. English-speaking. Previously consented NIDDK Phoenix study volunteers and new participants from the general population. Conducted online so physical location is unrestricted.

Who may be able to join

  • In order to be eligible to participate in this study, an individual must meet all the following criteria:
  • 18 years of age or older
  • Able to read and write English
  • Consistent access to computer or mobile devices connected to the internet
  • Able to provide informed consent online and/or in-person
  • In order to be eligible to participate in the EMA arm of the study, an individual must meet all the following criteria:
  • 1. Access to a mobile device with WI-FI and data

Who cannot join

  • 1. Non-English-speaking individuals.
  • Non-English-speaking subjects as a population will be excluded from participation in this protocol. The primary aim of the protocol relates to the questionnaires administered to the participants online. There are currently no validated, translated forms of these questionnaires available; therefore, we will restrict enrollment to English speaking subjects only.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • NIDDK, Phoenix

    Phoenix, Arizona, 85014

Other trials in United States

About this study

Official title: The Impact of the Food Environment and Psychosocial Stress From the COVID-19 Pandemic on Eating Behavior and Weight Change

Background:

The indirect effects of the COVID-19 pandemic on mental health are of increasing concern. Perceived stress can lead to binge eating and weight gain. Researchers want to learn more about the relationship between eating behavior and the pandemic.

Read more

Objective:

To study how the stress of the COVID-19 pandemic is affecting eating behaviors and weight.

Eligibility:

English-speaking adults ages 18 and older who have access to a computer or smartphone connected to the internet.

Design:

This is an online study. Participants will answer surveys through the study website.

Participants will complete a one-time survey. It will ask about their experiences throughout the COVID-19 pandemic, their socioeconomic standing, their mental and physical health, and their eating habits. They will have the option to repeat the survey once a month for the next 12 months. This will show changes in their thoughts and behaviors over time. They will provide their email address to get survey links.

Participants will also have the option to complete a 2-minute survey on their smartphone. They will complete the survey daily for 7 days in a row. It will ask about their stress and eating behavior in real time, in their home environment. They will provide their phone number to get survey links via text message.

If a participant has taken part in a previous NIH study on the Phoenix AZ campus, they will be asked to share their first and last name, date of birth, and email address. This information will be used to connect data from this study to their past data.

Participation is typically 25 minutes but may last up to 1 year.

*To participate in this study go to the REDCap study link: https://redcap.link/nihcovidstudy.*...

Read the detailed description

Study Description:

We will recruit previous NIDDK study participants as well as newly recruited individuals from the general population to examine how the COVID-19 pandemic has exacerbated the impact of psychosocial stressors that impact eating behavior and weight. The study will describe the relationship between specific COVID-19 related stressors (e.g. fear of becoming sick) and self-rated measures of food insecurity, unpredictability, perceived stress, behavioral health dysfunction, eating behaviors and weight change among a range of participants including previous NIDDK-Phoenix study volunteers and various newly recruited volunteers from the general global population. Participants will be invited to enroll in a follow- up study which will involve completing additional surveys on a monthly basis for 12 months. A smaller U.S. only cohort of these participants may also enroll in a 2 minute daily at-home survey study for 1-weekthat will utilize Ecological Momentary Assessment (EMA) to examine stress and eating behavior in real-time, in the home environment. Participants will complete an online consent form and online survey through a secure weblink (REDCap). Because the situation with the COVID-19 pandemic is rapidly changing, survey data collection is an effective way to measure outcomes at multiple time points with relatively low subject burden.

Objectives:

Primary Objective: to examine the food environment and psychosocial stressors related to COVID-19 with self-reported measures of behavioral health symptoms, eating behaviors and weight.

Secondary Objective: to determine whether sociodemographic, existing behavioral health dysfunction, or environmental condition moderates this relationship and to identify risk and resilience factors among study participants regarding the impact of the COVID-19 pandemic on eating behavior and weight.

Endpoints:

Primary Endpoints: measures of eating behavior and body weight. These endpoints will be measured repeatedly using an online platform (REDCap) at baseline and then monthly for up to 12 months. We also plan to examine these COVID-19 related measures with previously collected phenotypic data (e.g. biological samples and behavioral data) from former NIDDK-Phoenix participants.

Secondary Endpoints: in addition to those outlined as primary endpoints, we will examine data gathered from demographic forms and additional questionnaires measuring environmental conditions and psychosocial stress.

Conditions
COVID-19, Obesity
Keywords
Obesity, Food Intake, Food Insecurity, Resilience, Unpredictability, Natural History
Medical subject headings
COVID-19, Obesity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT04896060
Study groupRoleWhat they receive
Ecological Momentary Assessment (EMA) volunteersVolunteers with access to mobile device with Wi-Fi and data recruited for an additional 1-week daily assessment study utilizing EMA to examine COVID-19 related stress and eating behavior in real-time
General global population volunteersNewly recruited volunteers 18 and above from the general global population that agree to participate in the COVID study
NIDDK-Phoenix study volunteersPrevious research participants, who signed consents that allow data sharing that agree to participate in the COVID study

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Nighttime Eating Behavior

    2 questions taken from the Night Eating Diagnostic Questionnaire (NEDQ), a self-report questionnaire containing 14 questions about eating after the evening meal and waking up in the night to eat. Symptoms are rated on a 5-point Likert-type scale, which are then summed to obtain a NEQ Global Score.

    Measured: Baseline and 12 months

  2. The Intuitive Eating Scale-2 (IES-2)

    The IES-2 consists of 23-items measuring individuals tendency to follow their physical hunger and satiety cues when determining when, what, and how much to eat. Scores are rated on a 5-point Likert scale ranging from strongly disagree to strongly agree. Items are summed and an average score is computed for the entire scale and its four subscales.

    Measured: Baseline and 12 months

  3. Three Factor Eating Questionnaire (TFEQ)

    TFEQ consists of 18 items on a 4-point response scale (definitely true/mostly true/mostly false/definitely false) (scores recorded on a 0-100 scale). Higher scores in the respective scales are indicative of greater cognitive restraint, uncontrolled, or emotional eating.

    Measured: Baseline and 12 months

  4. Loss of Control Eating

    2 questions to assess eating a large amount of food and sense of loss of control over one s eating behavior

    Measured: Baseline and 12 months

  5. Food Frequency Questionnaire (FFQ)

    Semiquantitative self-administered questionnaire that estimates average daily intake of foods, drinks, energy, and major nutrients out of about 124 different foods.

    Measured: Baseline and 12 months

  6. Changes in self-reported weight

    Changes in self-reported weight from baseline to 12 months

    Measured: Baseline and 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 May 2021
  2. Study start1 Sep 2022
  3. Primary completion13 Feb 2025
  4. Study completion13 Feb 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Ecologic or community
Time perspective
Prospective
Enrolment
5,056 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04896060
Sponsor's protocol ID
10000172
Other IDs
000172-DK
Status last verified
26 Aug 2026
First submitted
19 May 2021
Last updated
28 Aug 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Willig M, Cabeza de Baca T, J Stinson E, M Trevino-Alvarez A, Rodzevik T, B Votruba S, C Lameman C, Krakoff J, Gluck ME. The impact of COVID-19 fear during the later stages of the pandemic on maladaptive eating, psychological distress and body weight: a global cross-sectional study. BMC Public Health. 2025 Apr 11;25(1):1365. doi: 10.1186/s12889-025-22444-6.

    PubMed 40217216

Questions about this trial

What is this clinical trial studying?

An observational study of COVID-19 and Obesity, run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Nighttime Eating Behavior (time frame: Baseline and 12 months). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04896060, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in